Dario Longo Selected Research

Antigens

6/2012

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dario Longo Research Topics

Disease

4	Neoplasms (Cancer) 01/2014 - 07/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Necrosis 06/2012
1	Experimental Melanoma 11/2011
1	Fibrosis (Cirrhosis) 07/2010
1	Wounds and Injuries (Trauma) 07/2010

Drug/Important Bio-Agent (IBA)

1	Proteins (Proteins, Gene)FDA Link 01/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014
1	VaccinesIBA 06/2012
1	AngiomotinsIBA 06/2012
1	AntigensIBA 06/2012
1	EpitopesIBA 06/2012
1	A-Form DNA (A-DNA)IBA 06/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2011
1	oxidized low density lipoproteinIBA 11/2011
1	TransglutaminasesIBA 07/2010
1	Factor XIII (Coagulation Factor XIII)IBA 07/2010
1	Contrast MediaIBA 07/2010
1	Protein Glutamine gamma Glutamyltransferase 2IBA 07/2010

Therapy/Procedure

1	Therapeutics 01/2014